Creating advanced animal models to improve diagnosis and treatment of rare diseases
UAB Pilot Center for Precision Animal Modeling (C-PAM) - Bioinformatics Section
This study is looking at the genetic differences that cause rare diseases to help doctors diagnose them better and find new treatments, using animal models that closely resemble human conditions, so we can understand these diseases more clearly.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10914828 on NIH RePORTER |
What this research studies
The UAB Center for Precision Animal Modeling (C-PAM) focuses on analyzing genetic variants linked to rare diseases to enhance diagnosis and identify potential therapeutic targets. By utilizing computational tools and methods, the research aims to develop informative animal models that can mimic human disease conditions. This involves a collaborative approach that integrates data from both human and animal studies, allowing for a comprehensive understanding of disease mechanisms. The Bioinformatics Section of C-PAM will provide essential support through data visualization, exploration, and analysis, ensuring that researchers can effectively utilize the generated models.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with rare genetic disorders who may benefit from advanced diagnostic and therapeutic strategies.
Not a fit: Patients with common diseases or those not linked to genetic variants may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnoses and targeted therapies for patients with rare diseases.
How similar studies have performed: Previous research has shown promise in using animal models for understanding rare diseases, indicating that this approach has potential for success.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Worthey, Elizabeth a — University of Alabama at Birmingham
- Study coordinator: Worthey, Elizabeth a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.